Showing results (861-870 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|January 16, 2007
An isotope-diagnostic approach to Erdheim-Chester's disease of the heartAndrás Palotás, Gábor Bogáts, Mátá Lázár, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 15, 2007
A review of the investigational antiarrhythmic agent dronedaroneMohammad J Tafreshi, Joie RowlesJournal of Cardiovascular Pharmacology and Therapeutics|May 15, 2007
Lipid-lowering therapy and outcomes in heart failureJoel G Ray, Colleen M Norris, Jacob A Udell, et al.Journal of Cardiovascular Pharmacology and Therapeutics|October 24, 2006
Ventricular fibrillation induced by ischemia-reperfusion is not prevented by the NPY Y2 receptor antagonist BIIE0246Arnfinn Ilebekk, Morten Eriksen, Knut Sevre, et al.Journal of Cardiovascular Pharmacology and Therapeutics|October 24, 2006
The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrateDimitrios S Christidis, Evangelos N Liberopoulos, Anna I Kakafika, et al.Journal of Cardiovascular Pharmacology and Therapeutics|August 14, 2010
The impact of paroxetine coadministration on stereospecific carvedilol pharmacokineticsStephen M Stout, Jace Nielsen, Barry E Bleske, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 18, 2010
Evaluation of antihypertensive therapy among ischemic stroke survivors: impact of ischemic heart diseaseYahaya Hassan, Noorizan Abd Aziz, Samah W Al-Jabi, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 18, 2010
Update on newer antihypertensive medicines and interventionsKatherine C Wu, Gary GerstenblithJournal of Cardiovascular Pharmacology and Therapeutics|May 18, 2010
Clinical pharmacology of dronedarone: implications for the therapy of atrial fibrillationPaul DorianJournal of Cardiovascular Pharmacology and Therapeutics|May 4, 2010
Early administration of small-molecule glycoprotein IIb/IIIa inhibitors before primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from randomized clinical trialsLili Dong, Feng Zhang, Xianhong ShuPageof 129